#Zolgensma #Zolgensma #Zolgensma

Zolgensma Approved!

AveXis, a Novartis company, has received FDA approval for Zolgensma.

Learn MoreLearn More
Cytokinetics Releases New Data from Reldesemtiv Clinical Study at the 2019 Annual SMA Conference

Cytokinetics Releases New Data from Reldesemtiv Clinical Study at the 2019 Annual SMA Conference

Cytokinetics, Incorporated,

READ MORE

Biogen Announces New NURTURE Data at the 2019 Annual SMA Conference

Biogen Announces New NURTURE Data at the 2019 Annual SMA Conference

Biogen

READ MORE

Updated SMA Drug Pipeline Now Available

Updated SMA Drug Pipeline Now Available

We’ve recently released an update to the SMA drug pipeline. This latest version includes:

What People Are Saying: 2019 North Jersey Walk-n-Roll

What People Are Saying: 2019 North Jersey Walk-n-Roll

The North Jersey Cure SMA Chapter held their 4th annual

READ MORE

The 2019 Annual SMA Conference is Here!

The 2019 Annual SMA Conference is Here!

The 2019 Annual SMA Conference, now in its 31st year, is set to kick off on June 28 and continue into a weekend full of

READ MORE

© 2019 Cure SMA | Cure SMA is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 36-3320440. | Privacy Policy

Powered by Blackbaud
nonprofit software